Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Br J Haematol. 2009 Mar 29;145(5):637–641. doi: 10.1111/j.1365-2141.2009.07670.x

Figure 1c.

Figure 1c

Overall survival of patients according to gene expression profiling (GEP) defined risk and the presence or absence of CA in both random sites and focal lesion sites (RS+/FL+). High-risk designation only lowers survival expectations in 22 among 236 patients lacking RS+/FL+ (“Not RS+/FL+”).